Amplia Therapeutics Limited (ASX: ATX), (“Amplia” or the “Company”), is pleased to announce important new data from our ongoing ACCENT clinical trial in pancreatic...
Eric Nuttall, partner and senior portfolio manager at Ninepoint Partners, shares his outlook for oil and natural gas, honing in on supply, demand and...
Saga Metals Corp. (‘SAGA’ or the ‘Company’) (TSXV: SAGA) (OTCQB: SAGMF) (FSE: 20H) a North American exploration company specializing in the discovery of critical...
American Salars Lithium Inc. (‘AMERICAN SALARS’ OR THE ‘COMPANY’) (CSE: USLI, OTC: ASALF, FWB: Z3P, WKN: A3E2NY ) announces the addition of Dr. Mark...
For months, investors have been on edge over U.S.-China tariff tensions, bracing for everything from fears of empty shelves to rising prices. But after...
Sarama Resources (SRR:AU) has announced Q1 2025 Management’s Discussion and Analysis Download the PDF here. This post appeared first on investingnews.com